Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Knowing when and how to realign your budget is crucial for maintaining financial stability. Explore the best practices to ensure timely adjustments.
28,655 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
As 2026 unfolds, a revival in wafer fab equipment spending arrives with tighter terms and higher tool prices, signali...
Qualcomm unveils an edge AI architecture designed to move data center AI power closer to devices. The move could resh...
A fresh analysis tests whether a $10,000 crypto investment can turn into $1 million by 2030, focusing on BTC, ETH, XR...
SK hynix kicked off trading at $170 on the Nasdaq, a 14% jump from the offering price of $149. The $26.5 billion deal...
Anthropic’s Dario Amodei says culture matters more than code in winning the AI race, dedicating up to 40% of his time...
A new analysis finds the pandemic born cohort of first and second graders continues to lag in math and reading compar...
A fresh look at Toyota, Brunswick, and Foresight ranks the best mobility stocks based on earnings power, cash flow, a...
Iran signals a selective pass-through policy at the Strait of Hormuz, potentially tightening oil flows and boosting m...
A leading XRP analyst lays out three bullish paths for XRP, each signaling multi-fold gains as crypto markets re-pric...
The WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
Nvidia rode the AI wave on the backs of gamers, but the industry’s shift toward AI workloads and cloud services is ch...